Patents by Inventor Sven Luettke

Sven Luettke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for treating urinary incontinence
    Patent number: 7019021
    Abstract: Compounds of the formula (II) wherein R1, R2, R3, R4, and R5 are as set forth herein, pharmaceutical compositions containing them, and their use in treating urinary incontinence.
    Type: Grant
    Filed: April 19, 2004
    Date of Patent: March 28, 2006
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Franz Esser, Helmut Staehle, Sven Luettke, Ikunobu Muramatsu, Hisato Kitagawa, Shuji Uchida
  • Compounds and methods for treating urinary incontinence
    Patent number: 6858594
    Abstract: The present invention relates to the use of ?1L-agonists for treating urinary incontinence.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: February 22, 2005
    Assignee: Boehringer Ingelheim Pharma GmbH & Co KG.
    Inventors: Franz Esser, Helmut Staehle, Sven Luettke, Ikunobu Muramatsu, Hisato Kitagawa, Shuji Uchida
  • Compounds and methods for treating urinary incontinence
    Publication number: 20040198796
    Abstract: Compounds of the formula (II) 1
    Type: Application
    Filed: April 19, 2004
    Publication date: October 7, 2004
    Applicant: Boehringer Ingelheim Pharma Gmbh & Co. KG
    Inventors: Franz Esser, Helmut Staehle, Sven Luettke, Ikunobu Muramatsu, Hisato Kitagawa, Shuji Uchida
  • Process for preparing a scopine ester intermediate
    Patent number: 6506900
    Abstract: The invention relates to a new process for preparing a scopine ester useful as an intermediate in preparing (1&agr;,2&bgr;,4&bgr;,5&agr;,7&bgr;)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4] nonane-bromide.
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: January 14, 2003
    Assignee: Boehringer Ingelheim Pharma AG
    Inventors: Rolf Banholzer, Manfred Graulich, Sven Luettke, Andreas Mathes, Helmut Meissner, Peter Specht, Wolfgang Broeder
  • Process for preparing an anticholinergic
    Patent number: 6486321
    Abstract: The invention relates to a new process for preparing (1&agr;,2&bgr;,4&bgr;,5&agr;,7&bgr;)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4] nonane-bromide.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: November 26, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Rolf Banholzer, Manfred Graulich, Sven Luettke, Andreas Mathes, Helmut Meissner, Peter Specht, Wolfgang Broeder
  • Intermediate compound for preparing guanidine and amidine derivatives
    Publication number: 20020147359
    Abstract: The invention relates to new compounds of general formula I 1
    Type: Application
    Filed: February 25, 2002
    Publication date: October 10, 2002
    Inventors: Sven Luettke, Andreas Mathes
  • Process for preparing guanidine and amidine derivatives
    Patent number: 6455700
    Abstract: The invention relates to new compounds of general formula I or the pharmaceutically acceptable salts thereof, wherein X=N—R3 or CH—R4, Y=CH2 or (CH2)2, Z=O or H2; and R1, R2, R3, R4 and Ar have the meanings given in the specification, and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: September 24, 2002
    Assignee: Boehringer Ingelheim Pharma KG.
    Inventors: Sven Luettke, Andreas Mathes
  • Process for preparing guanidine and amidine derivatives
    Publication number: 20020133012
    Abstract: The invention relates to new compounds of general formula I 1
    Type: Application
    Filed: February 27, 2002
    Publication date: September 19, 2002
    Inventors: Sven Luettke, Andreas Mathes
  • Process for preparing an anticholinergic
    Publication number: 20020133010
    Abstract: The invention relates to a new process for preparing (1&agr;,2&bgr;,4&bgr;,5&agr;,7&agr;)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide.
    Type: Application
    Filed: December 19, 2001
    Publication date: September 19, 2002
    Inventors: Rolf Banholzer, Manfred Graulich, Sven Luettke, Andreas Mathes, Helmut Meissner, Peter Specht, Wolfgang Broeder
  • Processes and intermediate compounds for preparing guanidine and amidine derivatives
    Patent number: 6429328
    Abstract: The invention relates to new compounds of general formula I or the pharmaceutically acceptable salts thereof, wherein X=N-R3 or CH-R4, Y=CH2 or (CH2)2, Z=O or H2; and R1, R2, R3, R4 and Ar have the meanings given in the specification, and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: August 6, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Sven Luettke, Andreas Mathes
  • Processes and intermediate compounds for preparing guanidine and amidine derivatives
    Publication number: 20020010173
    Abstract: The invention relates to new compounds of general formula I 1
    Type: Application
    Filed: July 2, 2001
    Publication date: January 24, 2002
    Inventor: Sven Luettke
  • Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds
    Patent number: 6277840
    Abstract: The invention relates to new compounds of general formula I or the pharmaceutically acceptable salts thereof, wherein X=N—R3 or CH—R4, Y=CH2 or (CH2)2, Z=O or H2; and R1, R2, R3, R4 and Ar have the meanings given in the specification, and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
    Type: Grant
    Filed: May 9, 2000
    Date of Patent: August 21, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Franz Esser, Gerd Schnorrenberg, Horst Dollinger, Sven Luettke, Birgit Jung, Georg Speck
  • Treatment of urinary incontinence by administration of &agr;1L-adrenoceptor agonists
    Patent number: 6268389
    Abstract: The present invention relates to the use of &agr;lL-agonists for treating urinary incontinence.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: July 31, 2001
    Assignee: Boehringer Ingelheim KG
    Inventors: Franz Esser, Helmut Staehle, Sven Luettke, Ikunobu Muramatsu, Hisato Kitagawa, Shuji Uchida
  • Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds
    Patent number: 6103719
    Abstract: The invention relates to new compounds of general formula I ##STR1## or the pharmaceutically acceptable salts thereof, wherein X=N--R.sup.3 or CH--R.sup.4,Y=CH.sub.2 or (CH.sub.2).sub.2,Z=O or H.sub.2 ;and R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Ar have the meanings given in the specification, and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: August 15, 2000
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Franz Esser, Gerd Schnorrenberg, Horst Dollinger, Sven Luettke, Birgit Jung, Georg Speck